Literature DB >> 25135733

Effects of IL-17 on expression of GRO-α and IL-8 in fibroblasts from nasal polyps.

Yong-Zhi Niu1, Guo-Qing Gong1, Shan Chen1, Jian-Jun Chen1, Wei-Jia Kong2, Yan-Jun Wang3.   

Abstract

Recent studies indicated that interleukin (IL)-17, growth-related oncogene (GRO)-α and IL-8 play an important role in the pathogenesis of nasal polyps. However, the effects of the increased amount of IL-17 and the production of GRO-α and IL-8 in human nasal polyp fibroblasts are not completely understood. This study aimed to determine the effects of the increased IL-17 on the changes of GRO-α and IL-8 expression in human nasal polyp fibroblasts and further investigate the mechanism of neutrophil infiltration in nasal polyps. Nasal polyp fibroblasts were isolated from six cases of human nasal polyps, and the cells were stimulated with five different concentrations of IL-17. Real-time fluorescence quantitative polymerase chain reaction (RT-PCR) was used to detect the mRNA expression of GRO-α and IL-8. The mRNA of GRO-α and IL-8 was expressed in unstimulated controls and remarkably increased by stimulation with IL-17. Moreover, the levels of GRO-α and IL-8 produced by fibroblasts were increased gradually with the increases in IL-17 concentrations. The present study showed that nasal fibroblasts can produce GRO-α and IL-8, and their production is remarkably enhanced by IL-17 stimulation, thereby clarifying the mechanism of the IL-17 mediated neutrophil infiltration in nasal polyps. These findings might provide a rationale for using IL-17 inhibitors as a treatment for nasal inflammatory diseases such as nasal polyps.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25135733     DOI: 10.1007/s11596-014-1321-1

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  31 in total

1.  IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines.

Authors:  S Molet; Q Hamid; F Davoine; E Nutku; R Taha; N Pagé; R Olivenstein; J Elias; J Chakir
Journal:  J Allergy Clin Immunol       Date:  2001-09       Impact factor: 10.793

2.  In vivo relationship between collagenase-2 and interleukin-8 but not tumour necrosis factor-alpha in chronic rhinosinusitis with nasal polyposis.

Authors:  K Kostamo; T Sorsa; M Leino; T Tervahartiala; H Alenius; M Richardson; E Toskala
Journal:  Allergy       Date:  2005-10       Impact factor: 13.146

3.  The characterization of IL-17A expression in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Xiao-Dan Jiang; Guang-Yu Li; Lin Li; Zhen Dong; Dong-Dong Zhu
Journal:  Am J Rhinol Allergy       Date:  2011 Sep-Oct       Impact factor: 2.467

4.  Combined stimulation with Poly(I:C), TNF-alpha and Th2 cytokines induces TARC production by human fibroblasts from the nose, bronchioles and lungs.

Authors:  Manabu Nonaka; Nozomu Ogihara; Akira Fukumoto; Atsuko Sakanushi; Kaoru Kusama; Ruby Pawankar; Toshiaki Yagi
Journal:  Int Arch Allergy Immunol       Date:  2010-02-26       Impact factor: 2.749

5.  EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.

Authors:  Wytske J Fokkens; Valerie J Lund; Joachim Mullol; Claus Bachert; Isam Alobid; Fuad Baroody; Noam Cohen; Anders Cervin; Richard Douglas; Philippe Gevaert; Christos Georgalas; Herman Goossens; Richard Harvey; Peter Hellings; Claire Hopkins; Nick Jones; Guy Joos; Livije Kalogjera; Bob Kern; Marek Kowalski; David Price; Herbert Riechelmann; Rodney Schlosser; Brent Senior; Mike Thomas; Elina Toskala; Richard Voegels; De Yun Wang; Peter John Wormald
Journal:  Rhinology       Date:  2012-03       Impact factor: 3.681

6.  Growth-related oncogene-alpha expression in human nasal polyps.

Authors:  A M Klein; K Anderson; D Lafreniere; G Leonard; D Kreutzer
Journal:  Otolaryngol Head Neck Surg       Date:  2000-07       Impact factor: 3.497

7.  IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells.

Authors:  J Witowski; K Pawlaczyk; A Breborowicz; A Scheuren; M Kuzlan-Pawlaczyk; J Wisniewska; A Polubinska; H Friess; G M Gahl; U Frei; A Jörres
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

8.  IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis.

Authors:  L Derycke; N Zhang; G Holtappels; T Dutré; C Bachert
Journal:  J Cyst Fibros       Date:  2011-12-16       Impact factor: 5.482

9.  The interleukin-17 pathway is involved in human alcoholic liver disease.

Authors:  Arnaud Lemmers; Christophe Moreno; Thierry Gustot; Raphaël Maréchal; Delphine Degré; Pieter Demetter; Patricia de Nadai; Albert Geerts; Eric Quertinmont; Vincent Vercruysse; Olivier Le Moine; Jacques Devière
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

10.  Gene expression profiles of nasal polyps associated with allergic rhinitis.

Authors:  Jian Wu; Liu Bing; He Jin; Fan Jingping
Journal:  Am J Otolaryngol       Date:  2008-07-09       Impact factor: 1.808

View more
  4 in total

1.  Expression of IL-17 and syndecan-1 in nasal polyps and their correlation with nasal polyps.

Authors:  Guo-Qing Gong; Fang-Fang Ren; Yan-Jun Wang; Lang Wan; Shan Chen; Jie Yuan; Chuan-Mei Yang; Bang-Hua Liu; Wei-Jia Kong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

2.  IL17 Mediates Pelvic Pain in Experimental Autoimmune Prostatitis (EAP).

Authors:  Stephen F Murphy; Anthony J Schaeffer; Joseph Done; Larry Wong; Ashlee Bell-Cohn; Kenny Roman; John Cashy; Michelle Ohlhausen; Praveen Thumbikat
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

Review 3.  Neutrophils as a Protagonist and Target in Chronic Rhinosinusitis.

Authors:  Hai Wang; Li Pan; Zheng Liu
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-08-10       Impact factor: 3.372

4.  Tc17/IL-17A Up-Regulated the Expression of MMP-9 via NF-κB Pathway in Nasal Epithelial Cells of Patients With Chronic Rhinosinusitis.

Authors:  Xiaohong Chen; Lihong Chang; Xia Li; Jiancong Huang; Luoying Yang; Xiaoping Lai; Zizhen Huang; Zhiyuan Wang; Xifu Wu; Jun Zhao; Joseph A Bellanti; Song Guo Zheng; Gehua Zhang
Journal:  Front Immunol       Date:  2018-09-19       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.